30 Years of Evidence
Featured Content
hypofractionated radiosurgery
Hypofractionated Radiosurgery (25 Gy/5 fractions) for Optic Nerve Sheath Meningiomas: Results from an Exploratory Phase 2 Prospective Trial
Spine Stereotactic body Radiation therapy
Efficacy and Safety of Donut-Shaped Circumferential Spine CyberKnife Stereotactic Body Radiotherapy for Metastatic Spine Disease
deep inspiration breath hold
Automated Deep Inspiration Breath-Hold (DIBH) in Breast Radiotherapy: A Comprehensive Assessment of the VitalHold System on the Radixact Platform
Hepatic Resection Versus Stereotactic Body Radiation Therapy Plus Transhepatic Arterial Chemoembolization for Large Hepatocellular Carcinoma: A Propensity Score Analysis
Sun J, Li WG, Wang Q, He WP, Wang HB, Han P, Zhang T, Zhang AM, Fan YZ, Sun YZ, Duan XZ | J Clin Transl Hepatol | 2021
Adjuvant stereotactic body radiotherapy after marginal resection for hepatocellular carcinoma with microvascular invasion: A randomised controlled trial
Shi C, Li Y, Geng L, Shen W, Sui C, Dai B, Lu J, Pan M, Yang J. | Eur J Cancer | 2022
Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
Lischalk JW, Malik RM, Collins SP, Collins BT, Matus IA, Anderson ED | Radiat Oncol. | 2016
Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation
Repka MC, Aghdam N, Kataria SK, Campbell L, Suy S, Collins SP, Anderson E, Lischalk JW, Collins BT | Radiat Oncol. | 2017
Factors affecting local control of pulmonary oligometastases treated with stereotactic body radiotherapy
Sharma A, Duijm M, Oomen-de Hoop E, Aerts JG, Verhoef C, Hoogeman M, Nuyttens JJ. | Acta Oncol | 2018
Long term efficacy and toxicity after stereotactic ablative reirradiation in locally relapsed stage III non-small cell lung cancer
Sumodhee S, Bondiau PY, Poudenx M, Cohen C, Naghavi AO, Padovani B, Maneval D, Gal J, Leysalle A, Ghalloussi H, Otto J, Doyen J | BMC Cancer | 2019
A 54 Gy in three fractions of stereotactic body radiotherapy using CyberKnife for T1b-2aN0M0 pathologically confirmed non-small cell lung cancer
Abe T, Ryuno Y, Iino M, Saito S, Aoshika T, Ohta T, Igari M, Hirai R, Kumazaki Y, Kaira K, Kagamu H, Ishida H, Noda SE, Kato S | Jpn J Clin Oncol. | 2021
Fiducial markers for stereotactic lung radiation therapy: review of the transthoracic, endovascular and endobronchial approaches
Alessio Casutt, Rémy Kinj, Esat-Mahmut Ozsahin, Christophe von Garnier, Alban Lovis | Eur Respir Rev | 2022
Image-Guided Robotic Radiosurgery for the Treatment of Lung Metastases of Renal Cell Carcinoma-A Retrospective, Single Center Analysis
Severin Rodler, Melanie Götz, Jan-Niclas Mumm, Alexander Buchner, Annabel Graser, Jozefina Casuscelli, Christian Stief, Christoph Fürweger, Alexander Muacevic, Michael Staehler | Cancers (Basel) | 2022
Safety and Efficacy of Stereotactic Ablative Radiotherapy for Ultra-Central Lung Cancer
Wang B, Dong Y, Yu X, Li F, Wang J, Chen H, Niu Z, Song Y, Yuan Z, Tao Z | Front Oncol | 2022
High-dose stereotactic body radiotherapy using CyberKnife® for stage I peripheral lung cancer: a single-center retrospective study
Ryuno Y, Abe T, Iino M, Saito S, Aoshika T, Oota T, Igari M, Hirai R, Kumazaki Y, Kaira K, Kagamu H, Ishida H, Noda SE, Kato S | Radiat Oncol | 2022
Ultrasound-Guided Placement of Gold Fiducial Markers for Stereotactic Partial-Breast Irradiation
Seiler S, Rahimi A, Choudhery S, Garwood D, Spangler A, Cherian S, Goudreau S. | AJR Am J Roentgenol | 2016
Preliminary Results of a Phase 1 Dose-Escalation Trial for Early-Stage Breast Cancer Using 5-Fraction Stereotactic Body Radiation Therapy for Partial-Breast Irradiation
Rahimi A, Thomas K, Spangler A, Rao R, Leitch M, Wooldridge R, Rivers A, Seiler S, Albuquerque K, Stevenson S, Goudreau S, Garwood D, Haley B, Euhus D, Heinzerling J, Ding C, Gao A, Ahn C, Timmerman R. | Int J Radiat Oncol Biol Phys | 2017
First Experience in Korea of Stereotactic Partial Breast Irradiation for Low-Risk Early-Stage Breast Cancer
Lee WH, Chang JS, Kim MJ, Park VY, Yoon JH, Kim SY, Kim JY, Park HS, Kim SI, Cho YU, Park BW, Kim YB. | Front Oncol | 2020
Implementation of Stereotactic Accelerated Partial Breast Irradiation Using Cyber-Knife – Technical Considerations and Early Experiences of a Phase II Clinical Study
Mészáros N, Smanykó V, Major T, Stelczer G, Jánváry L, Kovács E, Mária B, Zaka Z, Pukancsik D, Takácsi-Nagy Z, Polgár C | Pathol Oncol Res | 2020
Simultaneous integrated boost with helical arc radiotherapy of total skin (HEARTS) to treat cutaneous manifestations of advanced, therapy-refractory cutaneous lymphoma and leukemia – dosimetry comparison of different regimens and clinical application
Hsieh CH, Tien HJ, Yu YB, Wu YH, Shueng PW, Lu YF, Wang SY, Wang LY | Radiat Oncol | 2019
A Helical tomotherapy as a robust low-dose treatment alternative for total skin irradiation
Haraldsson A, Engleson J, Bäck SÅJ, Engelholm S, Engström PE | J Appl Clin Med Phys | 2019
Effectiveness and Safety of Tissue Expander for Adjuvant Helical Tomotherapy in Curatively Resected Retroperitoneal Sarcoma
Yu JI, Lim DH, Park HC, Jung SH, Jeon SJ, Nam H, Kim B, Kim SJ, Park JB | Anticancer Res | 2018
Neoadjuvant image-guided helical intensity modulated radiotherapy of extremity sarcomas – a single center experience
Peeken JC, Knie C, Kessel KA, Habermehl D, Kampfer S, Dapper H, Devecka M, von Eisenhart-Rothe R, Specht K, Weichert W, Wörtler K, Knebel C, Wilkens JJ, Combs SE | Radiat Oncol | 2019
Prospective evaluation of multitarget treatment of pediatric patients with helical intensity-modulated radiotherapy
Salfelder MA, Kessel KA, Thiel U, Burdach S, Kampfer S, Combs SE | Strahlenther Onkol | 2020
Efficacy and toxicity of chemoradiation in patients with anal cancer–a retrospective analysis
Koerber SA, Slynko A, Haefner MF, Krug D, Schoneweg C, Kessel K, Kopp-Schneider A, Herfarth K, Debus J, Sterzing F | Radiat Oncol | 2014
Patient reported quality of life after helical IMRT based concurrent chemoradiation of locally advanced anal cancer
Joseph K, Vos LJ, Warkentin H, Paulson K, Polkosnik LA, Usmani N, Tankel K, Severin D, Nijjar T, Schiller D, Wong C, Ghosh S, Mulder K, Field C | Radiother Oncol | 2016
Modern intensity-modulated radiotherapy with image guidance allows low toxicity rates and good local control in chemoradiotherapy for anal cancer patients
De Bari B, Lestrade L, Franzetti-Pellanda A, Jumeau R, Biggiogero M, Kountouri M, Matzinger O, Miralbell R, Bourhis J, Ozsahin M, Zilli T | J Cancer Res Clin Oncol | 2018
